MedTrace Logo

Effectiveness of Probiotics in Patients of Mild to Moderate Rheumatoid Arthritis

NCT06594822 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2024-09-19

No results posted yet for this study

Summary

To assess the effectiveness of probiotics when given in combination with standard therapy in patients of mild to moderate rheumatoid arthritis

Conditions

Interventions

DIETARY_SUPPLEMENT

probiotic plus standard treatment

Bacillus clausii, 5ml ampule containing 2 billion spores, given orally once daily

DRUG

standard treatment

diclofenac 50 mg twice a day, prednisone 5mg once daily, methotrexate 10mg once weekly or sulfasalazine 500 twice daily

Sponsors & Collaborators

  • King Edward Medical University

    lead OTHER

Principal Investigators

  • Gulraiz Iqbal, MBBS · King Edward Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-24
Primary Completion
2024-01-23
Completion
2024-02-23

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06594822 on ClinicalTrials.gov